Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can ...

Breelyn Wilky, MD, discusses what precision oncology advancements will most impact gastrointestinal stromal tumor management in the next 3 to 5 years.

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists.

251776 Introduction: Recently, there are some studies showing the value of 68Ga-DOTA-FAPI-04 PET in the detection of metastatic gastrointestinal stromal tumor (GIST). However, only a few cases have ...

In this observational cohort study, we considered for inclusion all patients who underwent resection of primary, non-metastatic GISTs at the Memorial Sloan Kettering Cancer Center (MSKCC; New York, NY ...

Adjuvant imatinib treatment for 3 years is recommended for patients with localized gastrointestinal stromal tumor (GIST) and a significant risk of relapse. 1 Several risk classifications have been ...

Gastrointestinal stromal tumors (GIST) are a type of soft tissue sarcoma. While they are the most common type of digestive tract sarcoma, they account for only 0.2% of digestive tract cancers overall.

Keywords Stromal Tumor, Gastrointestinal, Epidemiology, Diagnosis Share and Cite: Nomenjanahary, L. , Rabarison, M. , Razafimahefa, V. and Randrianjafisamindrakotroka, N. (2022) Mesenchymal Tumors in ...

Example of visualization codes for the article "A deep learning-based system trained for gastrointestinal stromal tumor screening can identify multiple types of soft tissue tumors" published in The ...

Gastrointestinal stromal tumor is the most common neoplasm of mesenchymal origin, 1 with an annual incidence of approximately 6,000 cases in the United States. Most cases are driven by oncogenic KIT 2 ...

A patient’s genotype is significantly associated with the risk of gastrointestinal stromal tumor (GIST) recurrence, according to a new study published in the Annals of Gastroenterological Surgery.

A breakthrough took place in 2004, when a novel gene, DOG1, was discovered. Its role in the pathology of GIST was unclear until 2013, when it was revealed that it played a crucial role in modulating ...